A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular Carcinoma
Shanghai Changzheng Hospital
Shanghai Changzheng Hospital
Disruptive Pharma
Emory University
Mayo Clinic
Jonsson Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Beijing Ditan Hospital
Boston Scientific Corporation
China Academy of Chinese Medical Sciences
First Affiliated Hospital Xi'an Jiaotong University
Beijing Ditan Hospital
Massachusetts General Hospital
University of Alabama at Birmingham
National Institutes of Health Clinical Center (CC)
Siemens Molecular Imaging